Table 2 Neutralization capacity of the pooled antisera against CA16 viruses.

From: A Broadly Cross-protective Vaccine Presenting the Neighboring Epitopes within the VP1 GH Loop and VP2 EF Loop of Enterovirus 71

Pooled antisera

100 μg/dose

10 μg/dose

190

4479

4430

213a

G10

190

4479

4430

213a

G10

Anti-HBc-E1/2

1:16

1:16

1:16

1:16

1:8

1:8

1:8

<1:8

1:16

<1:8

Anti-HBc-E1

<1:8

<1:8

<1:8

<1:8

<1:8

<1:8

<1:8

<1:8

<1:8

<1:8

Anti-HBc-E2

1:8

1:16

1:16

1:8

1:8

<1:8

<1:8

<1:8

1:8

<1:8

Anti-HBc(aa1-149)

<1:8

<1:8

<1:8

<1:8

<1:8

<1:8

<1:8

<1:8

<1:8

<1:8

adjuvant

<1:8

<1:8

<1:8

<1:8

<1:8

<1:8

<1:8

<1:8

<1:8

<1:8

  1. The lowest serum dilution tested was 1:8. Antibody titers were determined using a in vitro assay, as described in the study. Antisera were collected at 2 weeks after 2nd booster injection.
Back to article page